Major Depressive Disorder Clinical Trials in Toms River, New Jersey

3 studies are recruiting for major depressive disorder in Toms River, New Jersey right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

    X-NOVA3 is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of azetukalner as a monotherapy in adult participants diagnosed with Major Depressive Disorder (MDD)

    Stage
    Phase 3
    Ages
    18 to 74
    Site
    Bio Behavioral Health, Toms River, New Jersey
    Locations
    50 in total
    Run by
    Xenon Pharmaceuticals Inc.

    See if you can join NCT07076407 on ClinicalTrials.gov

  2. Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

    This is a multicenter, randomized, double-blind, placebo-controlled parallel-group, fixed-dose study in patients with a primary diagnosis of MDD according to criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) who have an inadequate response to ongoing ADT.

    Stage
    Phase 3
    Ages
    18 to 65
    Site
    Bio Behavioral Health, Toms River, New Jersey
    Locations
    69 in total
    Run by
    Intra-Cellular Therapies, Inc.

    See if you can join NCT05850689 on ClinicalTrials.gov

  3. A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

    This is a randomized, double-blind, active-controlled, multi-center study to evaluate the efficacy of AXS-05, compared to bupropion, in preventing the relapse of depressive symptoms in subjects with major depressive disorder (MDD) who have responded to treatment with AXS-05.

    Stage
    Phase 4
    Ages
    18 to 65
    Site
    Clinical Research Site, Toms River, New Jersey
    Locations
    40 in total
    Run by
    Axsome Therapeutics, Inc.

    See if you can join NCT06223880 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.